Kusajili – Clinical trials directory

Result of your search per sponsor: Janssen Cliag Ltd. C/O Johnson & Johnson PRD

Man Max 99 years
Janssen Cliag Ltd. C/O Johnson & Johnson PRD Update Il y a 4 ans

A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS To determine whether R317573, after multiple dosing over one week, reduces the intensity of an anxiogenic reaction induced by the intravenous (i.v.) administration of cholecystokinin-tetrapeptide (CCK...

Country None
organs None
Specialty None

unknown

More information